ASCENTAGE-B(06855): The trustee will purchase a total of 100,000 restricted share units in 2022.

date
21:58 27/05/2026
avatar
GMT Eight
Asia Pharmaceutical-B (06855) announced that on May 27, 2026, the trustee will purchase a total of 100,000 existing shares on the market to meet the restricted share unit plan for 2022 after attribution.
ASCENTAGE-B (06855) announced on May 27, 2026, that the trustee purchased a total of 100,000 existing shares on the market on behalf of the 2022 Restricted Stock Unit Plan to fulfill the restricted stock units after vesting.